Joseph E Palys

Array ( [id] => 3614162 [patent_doc_number] => 05565549 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-15 [patent_title] => 'CD8.sup.+ cell antiviral factor' [patent_app_type] => 1 [patent_app_number] => 8/122221 [patent_app_country] => US [patent_app_date] => 1993-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5577 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/565/05565549.pdf [firstpage_image] =>[orig_patent_app_number] => 122221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2991938 [patent_doc_number] => 05346989 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-09-13 [patent_title] => 'Peptides for use in induction of T cell activation against HIV-1' [patent_app_type] => 1 [patent_app_number] => 8/121032 [patent_app_country] => US [patent_app_date] => 1993-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13473 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/346/05346989.pdf [firstpage_image] =>[orig_patent_app_number] => 121032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3821887 [patent_doc_number] => 05783216 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-21 [patent_title] => 'Methods for inhibiting rejection of transplanted tissue' [patent_app_type] => 1 [patent_app_number] => 8/112709 [patent_app_country] => US [patent_app_date] => 1993-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 5149 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/783/05783216.pdf [firstpage_image] =>[orig_patent_app_number] => 112709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3588026 [patent_doc_number] => 05585250 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-17 [patent_title] => 'Dampening of an immunodominant epitope of an antigen for use in plant, animal and human compositions and immunotherapies' [patent_app_type] => 1 [patent_app_number] => 8/109934 [patent_app_country] => US [patent_app_date] => 1993-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 10725 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/585/05585250.pdf [firstpage_image] =>[orig_patent_app_number] => 109934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4041588 [patent_doc_number] => 05869053 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => '5T4 antigen from human trophoblasts' [patent_app_type] => 1 [patent_app_number] => 8/108144 [patent_app_country] => US [patent_app_date] => 1993-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 11188 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869053.pdf [firstpage_image] =>[orig_patent_app_number] => 108144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3523715 [patent_doc_number] => 05503974 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-02 [patent_title] => 'Retrovirus detection' [patent_app_type] => 1 [patent_app_number] => 8/106145 [patent_app_country] => US [patent_app_date] => 1993-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 7241 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/503/05503974.pdf [firstpage_image] =>[orig_patent_app_number] => 106145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3835173 [patent_doc_number] => 05744144 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-28 [patent_title] => 'Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/099354 [patent_app_country] => US [patent_app_date] => 1993-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 29 [patent_no_of_words] => 14684 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/744/05744144.pdf [firstpage_image] =>[orig_patent_app_number] => 099354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3828393 [patent_doc_number] => 05711947 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-27 [patent_title] => 'Method to induce cytotoxic T Lymphocytes specific for a broad array of HIV-1 isolates using hybrid synthetic peptides' [patent_app_type] => 1 [patent_app_number] => 8/095332 [patent_app_country] => US [patent_app_date] => 1993-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 6704 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/711/05711947.pdf [firstpage_image] =>[orig_patent_app_number] => 095332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3119221 [patent_doc_number] => 05384122 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-01-24 [patent_title] => 'Herpesvirus particles and vaccine' [patent_app_type] => 1 [patent_app_number] => 8/095041 [patent_app_country] => US [patent_app_date] => 1993-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 8722 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/384/05384122.pdf [firstpage_image] =>[orig_patent_app_number] => 095041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3753520 [patent_doc_number] => 05843422 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Method and compositions for treating injury' [patent_app_type] => 1 [patent_app_number] => 8/076086 [patent_app_country] => US [patent_app_date] => 1993-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 5537 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843422.pdf [firstpage_image] =>[orig_patent_app_number] => 076086 [rel_patent_id] =>[rel_patent_doc_number] =>)